1st Quarter - Termination
BOCKORNY GROUP, INC. for GENERIC PHARMACEUTICAL ASSOCIATION
Firm
Income
$20,000
Expenses
—
Terminated
Feb 2, 2016
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues Related to Biosimilar Regulation, Labeling, E-Labeling and Access
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOCKORNY | — |
| BLAIR C LARKINS | — |
| BERNARD ROTHSCHILD | — |
| NICOLE VENABLE | — |
Trade (domestic/foreign) TRD
Issues Related to Global Health Negotiations as Part of the ongoing TPP Negotiations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE VENABLE | — |
Health Issues HCR
Drug Affordability and Access Issues 21st Century Cures Initiative and Related Legislative Proposals Advanced Medicines Initiative HR 2841, FAST Generics Act of 2015 (Fair Access for Safe and Timely Generics)
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOCKORNY | — |
| BLAIR C LARKINS | — |
| BERNARD ROTHSCHILD | — |
| NICOLE VENABLE | — |
Budget/Appropriations BUD
Ag-appropriations language related to labeling issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| BLAIR C LARKINS | — |
| NICOLE VENABLE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.